NORTHERN TRUST CORP - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 48 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$21,000
-36.4%
123,6690.0%0.00%
Q2 2022$33,000
-52.2%
123,6690.0%0.00%
Q1 2022$69,000
-21.6%
123,669
-0.6%
0.00%
Q4 2021$88,000
-56.4%
124,3690.0%0.00%
Q3 2021$202,000
-26.0%
124,369
-9.1%
0.00%
Q2 2021$273,000
-71.9%
136,872
-53.2%
0.00%
Q1 2021$970,000
-24.3%
292,217
-9.3%
0.00%
Q4 2020$1,282,000
+50.1%
322,099
-0.8%
0.00%
Q3 2020$854,000
-17.4%
324,857
-4.9%
0.00%
Q2 2020$1,034,000
+67.0%
341,460
+8.1%
0.00%
Q1 2020$619,000
-70.9%
315,904
+9.4%
0.00%
Q4 2019$2,125,000
+61.0%
288,731
-1.1%
0.00%
Q3 2019$1,320,000
-55.9%
291,931
-2.8%
0.00%
-100.0%
Q2 2019$2,993,000
-10.7%
300,197
+4.6%
0.00%0.0%
Q1 2019$3,353,000
-0.8%
287,081
+2.0%
0.00%0.0%
Q4 2018$3,381,000
-29.6%
281,534
-0.2%
0.00%0.0%
Q3 2018$4,805,000
+269.9%
281,981
+270.6%
0.00%
Q2 2018$1,299,00076,0880.00%
Other shareholders

There were no reported owners of ELOXX PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of ELOXX PHARMACEUTICALS INC shareholders